Free Trial

Jin Medical International (ZJYL) Competitors

Jin Medical International logo
$2.25 -0.22 (-8.91%)
Closing price 06/8/2026 04:00 PM Eastern
Extended Trading
$2.18 -0.07 (-3.11%)
As of 06:31 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ZJYL vs. LNSR, BDMD, LUNG, APT, and QTI

Should you buy Jin Medical International stock or one of its competitors? MarketBeat compares Jin Medical International with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Jin Medical International include LENSAR (LNSR), Baird Medical Investment (BDMD), Pulmonx (LUNG), Alpha Pro Tech (APT), and QT Imaging (QTI). These companies are all part of the "medical equipment" industry.

How does Jin Medical International compare to LENSAR?

Jin Medical International (NASDAQ:ZJYL) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, analyst recommendations, dividends, media sentiment, earnings, institutional ownership and valuation.

Jin Medical International has higher earnings, but lower revenue than LENSAR.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$20.69M0.85$1.19MN/AN/A
LENSAR$58.44M1.16-$34.28M-$0.58N/A

LENSAR has a net margin of 50.94% compared to Jin Medical International's net margin of 0.00%. Jin Medical International's return on equity of 0.00% beat LENSAR's return on equity.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
LENSAR 50.94%-183.19%42.26%

Jin Medical International has a beta of 7.24, suggesting that its share price is 624% more volatile than the broader market. Comparatively, LENSAR has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market.

In the previous week, LENSAR had 1 more articles in the media than Jin Medical International. MarketBeat recorded 2 mentions for LENSAR and 1 mentions for Jin Medical International. Jin Medical International's average media sentiment score of 0.00 beat LENSAR's score of -0.34 indicating that Jin Medical International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Jin Medical International
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
LENSAR
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

LENSAR has a consensus price target of $10.00, indicating a potential upside of 78.57%. Given LENSAR's stronger consensus rating and higher possible upside, analysts clearly believe LENSAR is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
LENSAR
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

40.2% of LENSAR shares are owned by institutional investors. 66.0% of LENSAR shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

LENSAR beats Jin Medical International on 10 of the 14 factors compared between the two stocks.

How does Jin Medical International compare to Baird Medical Investment?

Jin Medical International (NASDAQ:ZJYL) and Baird Medical Investment (NASDAQ:BDMD) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Baird Medical Investment
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Jin Medical International has a beta of 7.24, indicating that its stock price is 624% more volatile than the broader market. Comparatively, Baird Medical Investment has a beta of -1.22, indicating that its stock price is 222% less volatile than the broader market.

In the previous week, Jin Medical International had 1 more articles in the media than Baird Medical Investment. MarketBeat recorded 1 mentions for Jin Medical International and 0 mentions for Baird Medical Investment. Jin Medical International's average media sentiment score of 0.00 equaled Baird Medical Investment'saverage media sentiment score.

Company Overall Sentiment
Jin Medical International Neutral
Baird Medical Investment Neutral

Jin Medical International has higher earnings, but lower revenue than Baird Medical Investment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$20.69M0.85$1.19MN/AN/A
Baird Medical Investment$22.54M2.33N/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
Baird Medical Investment N/A N/A N/A

19.8% of Baird Medical Investment shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Baird Medical Investment beats Jin Medical International on 4 of the 6 factors compared between the two stocks.

How does Jin Medical International compare to Pulmonx?

Jin Medical International (NASDAQ:ZJYL) and Pulmonx (NASDAQ:LUNG) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, media sentiment, earnings and dividends.

Jin Medical International has a net margin of 0.00% compared to Pulmonx's net margin of -60.09%. Jin Medical International's return on equity of 0.00% beat Pulmonx's return on equity.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
Pulmonx -60.09%-92.94%-39.80%

Pulmonx has a consensus price target of $5.58, suggesting a potential upside of 274.72%. Given Pulmonx's stronger consensus rating and higher possible upside, analysts clearly believe Pulmonx is more favorable than Jin Medical International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Pulmonx
1 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.43

Jin Medical International has a beta of 7.24, indicating that its share price is 624% more volatile than the broader market. Comparatively, Pulmonx has a beta of 0.28, indicating that its share price is 72% less volatile than the broader market.

In the previous week, Jin Medical International and Jin Medical International both had 1 articles in the media. Jin Medical International's average media sentiment score of 0.00 beat Pulmonx's score of -0.15 indicating that Jin Medical International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Jin Medical International
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Pulmonx
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Jin Medical International has higher earnings, but lower revenue than Pulmonx.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$20.69M0.85$1.19MN/AN/A
Pulmonx$90.50M0.70-$54M-$1.30N/A

91.0% of Pulmonx shares are owned by institutional investors. 6.8% of Pulmonx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Jin Medical International beats Pulmonx on 7 of the 13 factors compared between the two stocks.

How does Jin Medical International compare to Alpha Pro Tech?

Jin Medical International (NASDAQ:ZJYL) and Alpha Pro Tech (NYSE:APT) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

22.7% of Alpha Pro Tech shares are owned by institutional investors. 15.0% of Alpha Pro Tech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Alpha Pro Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Alpha Pro Tech has higher revenue and earnings than Jin Medical International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jin Medical International$20.69M0.85$1.19MN/AN/A
Alpha Pro Tech$59.91M0.93$4.19M$0.3515.63

In the previous week, Jin Medical International and Jin Medical International both had 1 articles in the media. Jin Medical International's average media sentiment score of 0.00 equaled Alpha Pro Tech'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Jin Medical International
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alpha Pro Tech
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Alpha Pro Tech has a net margin of 6.99% compared to Jin Medical International's net margin of 0.00%. Alpha Pro Tech's return on equity of 6.70% beat Jin Medical International's return on equity.

Company Net Margins Return on Equity Return on Assets
Jin Medical InternationalN/A N/A N/A
Alpha Pro Tech 6.99%6.70%5.76%

Jin Medical International has a beta of 7.24, indicating that its share price is 624% more volatile than the broader market. Comparatively, Alpha Pro Tech has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market.

Summary

Alpha Pro Tech beats Jin Medical International on 8 of the 10 factors compared between the two stocks.

How does Jin Medical International compare to QT Imaging?

QT Imaging (NASDAQ:QTI) and Jin Medical International (NASDAQ:ZJYL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership and valuation.

QT Imaging has a beta of -0.07, suggesting that its stock price is 107% less volatile than the broader market. Comparatively, Jin Medical International has a beta of 7.24, suggesting that its stock price is 624% more volatile than the broader market.

Jin Medical International has a net margin of 0.00% compared to QT Imaging's net margin of -58.93%. Jin Medical International's return on equity of 0.00% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
QT Imaging-58.93% -4,220.38% -51.77%
Jin Medical International N/A N/A N/A

Jin Medical International has higher revenue and earnings than QT Imaging.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QT Imaging$18.92M2.42-$21.08M-$1.24N/A
Jin Medical International$20.69M0.85$1.19MN/AN/A

24.2% of QT Imaging shares are held by institutional investors. 28.8% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, QT Imaging and QT Imaging both had 1 articles in the media. QT Imaging's average media sentiment score of 0.00 equaled Jin Medical International'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QT Imaging
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Jin Medical International
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Jin Medical International
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Jin Medical International beats QT Imaging on 6 of the 11 factors compared between the two stocks.

Get Jin Medical International News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZJYL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ZJYL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ZJYL vs. The Competition

MetricJin Medical InternationalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$19.33M$8.40B$6.48B$11.99B
Dividend YieldN/A2.52%2.67%5.58%
P/E RatioN/A16.1623.6923.74
Price / Sales0.857.12512.55110.46
Price / Cash13.4817.4526.9937.25
Price / Book0.603.5510.466.78
Net Income$1.19M$225.32M$3.57B$337.51M
7 Day Performance-30.77%0.58%0.25%-2.34%
1 Month Performance6.13%2.21%3.24%1.88%
1 Year Performance-83.48%-3.45%22.21%25.55%

Jin Medical International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZJYL
Jin Medical International
0.2902 of 5 stars
$2.25
-8.9%
N/A-85.4%$19.33M$20.69MN/A245
LNSR
LENSAR
1.8717 of 5 stars
$6.05
-0.7%
$10.00
+65.3%
-57.3%$73.71M$57.70MN/A110
BDMD
Baird Medical Investment
0.9012 of 5 stars
$1.58
-3.1%
N/A-71.5%$66.80M$22.54MN/AN/A
LUNG
Pulmonx
2.433 of 5 stars
$1.57
+1.3%
$5.58
+255.6%
-53.0%$65.47M$88.55MN/A250
APT
Alpha Pro Tech
N/A$6.05
-3.5%
N/A+20.0%$61.81M$59.91M16.35120

Related Companies and Tools


This page (NASDAQ:ZJYL) was last updated on 6/9/2026 by MarketBeat.com Staff.
From Our Partners